Genetic variants at chromosome 9p21 and risk of first versus subsequent coronary heart disease events: A systematic review and meta-analysis

Journal of the American College of Cardiology

Volumn 63, Issue 21, 2014, Pages 2234-2245

  Patel, Riyaz S ^a,b   Asselbergs, Folkert W ^a,c,d   Quyyumi, Arshed A ^e   Palmer, Tom M ^f   Finan, Chris I ^a   Tragante, Vinicius ^c   Deanfield, John ^a   Hemingway, Harry ^a   Hingorani, Aroon D ^a   Holmes, Michael V ^a,g  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF WARWICK   (United Kingdom)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

9p21; coronary heart disease; genomics; incident; subsequent

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; CHROMOSOME; CHROMOSOME 9P21; COMPARATIVE STUDY; DISEASE COURSE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC VARIABILITY; HAZARD RATIO; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; ALLELE; CHROMOSOME 9P; CORONARY RISK; FOLLOW UP; HETEROZYGOSITY; HOMOZYGOSITY; SINGLE NUCLEOTIDE POLYMORPHISM;

9P21; CORONARY HEART DISEASE; GENOMICS; INCIDENT; SUBSEQUENT;

ANIMALS; CHROMOSOMES, HUMAN, PAIR 9; CORONARY DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84901631415     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.01.065     Document Type: Article

References (57)

1. R. McPherson, A. Pertsemlidis, and N. Kavaslar et al. A common allele on chromosome 9 associated with coronary heart disease Science 316 2007 1488 1491
2. A. Helgadottir, G. Thorleifsson, and A. Manolescu et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction Science 316 2007 1491 1493
3. N.J. Samani, J. Erdmann, and A.S. Hall et al. Genomewide association analysis of coronary artery disease N Engl J Med 357 2007 443 453
4. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls Nature 447 2007 661 678
5. P.J. Talmud, J.A. Cooper, and J. Palmen et al. Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men Clin Chem 54 2008 467 474
6. S. Ye, J. Willeit, F. Kronenberg, Q. Xu, and S. Kiechl Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study J Am Coll Cardiol 52 2008 378 384
7. J. Karvanen, K. Silander, and F. Kee et al. The impact of newly identified loci on coronary heart disease, stroke and total mortality in the MORGAM prospective cohorts Genet Epidemiol 33 2009 237 246
8. A. Dutta, W. Henley, and I.A. Lang et al. The coronary artery disease-associated 9p21 variant and later life 20-year survival to cohort extinction Circ Cardiovasc Genet 4 2011 542 548
9. D. Ardissino, C. Berzuini, and P.A. Merlini et al. Influence of 9p21.3 genetic variants on clinical and angiographic outcomes in early-onset myocardial infarction J Am Coll Cardiol 58 2011 426 434
10. Y. Gong, A.L. Beitelshees, and R.M. Cooper-DeHoff et al. Chromosome 9p21 haplotypes and prognosis in white and black patients with coronary artery disease Circ Cardiovasc Genet 4 2011 169 178
11. B.D. Horne, J.F. Carlquist, J.B. Muhlestein, T.L. Bair, and J.L. Anderson Association of variation in the chromosome 9p21 locus with myocardial infarction versus chronic coronary artery disease Circ Cardiovasc Genet 1 2008 85 92
12. R.S. Patel, D.J. Eapen, A.M. Zafari, V. Vaccarino, and A.A. Quyyumi Letter by Patel et al regarding article "Chromosome 9p21 haplotypes and prognosis in white and black patients with coronary artery disease." Circ Cardiovasc Genet 4 2011 e11 author reply e12
13. S.S. Virani, A. Brautbar, and V.V. Lee et al. Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease Circ J 76 2012 950 956
14. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman for the PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 6 2009 e1000097
15. C.R. Simpson, B.S. Buckley, D.J. McLernon, A. Sheikh, A. Murphy, and P.C. Hannaford Five-year prognosis in an incident cohort of people presenting with acute myocardial infarction PloS One 6 2011 e26573
16. M.J. Goldacre, S.E. Roberts, and M. Griffith Place, time and certified cause of death in people who die after hospital admission for myocardial infarction or stroke Eur J Public Health 14 2004 338 342
17. M.G. Andreassi, D. Adlerstein, and C. Carpeggiani et al. Individual and summed effects of high-risk genetic polymorphisms on recurrent cardiovascular events following ischemic heart disease Atherosclerosis 223 2012 409 415
18. P. Hoppmann, A. Erl, and S. Turk et al. No association of chromosome 9p21.3 variation with clinical and angiographic outcomes after placement of drug-eluting stents J Am Coll Cardiol Intv 2 2009 1149 1155
19. W.H. Peng, L. Lu, and Q. Zhang et al. Chromosome 9p21 polymorphism is associated with myocardial infarction but not with clinical outcome in Han Chinese Clin Chem Lab Med 47 2009 917 922
20. D.G. Altman, and J.M. Bland Interaction revisited: the difference between two estimates BMJ 326 2003 219
21. NCBI. dbSNP Short Genetic Variations. Available at: http://www.ncbi.nlm. nih.gov/SNP. Accessed July 21, 2013
22. S. Purcell, S.S. Cherny, and P.C. Sham Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits Bioinformatics 19 2003 149 150
23. R.S. Patel, Y.V. Sun, and J. Hartiala et al. Association of a genetic risk score with prevalent and incident myocardial infarction in subjects undergoing coronary angiography Circ Cardiovasc Genet 5 2012 441 449
24. A. Dehghan, M. van Hoek, and E.J. Sijbrands et al. Lack of association of two common polymorphisms on 9p21 with risk of coronary heart disease and myocardial infarction; results from a prospective cohort study BMC Med 6 2008 30
25. K.L. Ellis, A.P. Pilbrow, and C.M. Frampton et al. A common variant at chromosome 9P21.3 is associated with age of onset of coronary disease but not subsequent mortality Circ Cardiovasc Genet 3 2010 286 293
26. N. Franceschini, C. Carty, and P. Buzkova et al. Association of genetic variants and incident coronary heart disease in multiethnic cohorts: the PAGE study Circ Cardiovasc Genet 4 2011 661 672
27. L. Gioli-Pereira, P.C. Santos, N.E. Ferreira, W.A. Hueb, J.E. Krieger, and A.C. Pereira Higher incidence of death in multi-vessel coronary artery disease patients associated with polymorphisms in chromosome 9p21 BMC Cardiovasc Disord 12 2012 61
28. K. Gransbo, P. Almgren, and M. Sjogren et al. Chromosome 9p21 genetic variation explains 13% of cardiovascular disease incidence but does not improve risk prediction J Intern Med 274 2013 233 240
29. G.W. Landman, J.V. van Vliet-Ostaptchouk, and N. Kleefstra et al. Association between 9p21 genetic variants and mortality risk in a prospective cohort of patients with type 2 diabetes (ZODIAC-15) Cardiovasc Diabet 11 2012 138
30. C. Lluis-Ganella, I. Subirana, and G. Lucas et al. Assessment of the value of a genetic risk score in improving the estimation of coronary risk Atherosclerosis 222 2012 456 463
31. J.D. Muehlschlegel, K.Y. Liu, and T.E. Perry et al. Chromosome 9p21 variant predicts mortality after coronary artery bypass graft surgery Circulation 122 2010 S60 S65
32. N.P. Paynter, D.I. Chasman, J.E. Buring, D. Shiffman, N.R. Cook, and P.M. Ridker Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3 Ann Intern Med 150 2009 65 72
33. E. Tikkanen, A.S. Havulinna, A. Palotie, V. Salomaa, and S. Ripatti Genetic risk prediction and a 2-stage risk screening strategy for coronary heart disease Arterioscler Thromb Vasc Biol 33 2013 2261 2266
34. B. Wahlstrand, M. Orho-Melander, and L. Delling et al. The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension J Hypertens 27 2009 769 773
35. E. Wauters, K.F. Carruthers, and I. Buysschaert et al. Influence of 23 coronary artery disease variants on recurrent myocardial infarction or cardiac death: the GRACE Genetics Study Eur Heart J 34 2013 993 1001
36. A.A. Vaarhorst, Y. Lu, and B.T. Heijmans et al. Literature-based genetic risk scores for coronary heart disease: the Cardiovascular Registry Maastricht (CAREMA) prospective cohort study Circ Cardiovasc Genet 5 2012 202 209
37. G.E. Palomaki, S. Melillo, and L.A. Bradley Association between 9p21 genomic markers and heart disease: a meta-analysis JAMA 303 2010 648 656
38. C.D. Anderson, M.A. Nalls, and A. Biffi et al. The effect of survival bias on case-control genetic association studies of highly lethal diseases Cardiovasc Genet 4 2011 188 196
39. I.J. Dahabreh, and D.M. Kent Index event bias as an explanation for the paradoxes of recurrence risk research JAMA 305 2011 822 823
40. R.S. Patel, and S. Ye Genetic determinants of coronary heart disease: new discoveries and insights from genome-wide association studies Heart 97 2011 1463 1473
41. M.P. Reilly, M. Li, and J. He et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies Lancet 377 2011 383 392
42. J.B. Kim, A. Deluna, and I.N. Mungrue et al. Effect of 9p21.3 coronary artery disease locus neighboring genes on atherosclerosis in mice Circulation 126 2012 1896 1906
43. A. Visel, Y. Zhu, and D. May et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice Nature 464 2010 409 412
44. O. Jarinova, A.F. Stewart, and R. Roberts et al. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus Arterioscler Thromb Vasc Biol 29 2009 1671 1677
45. A. Motterle, X. Pu, and H. Wood et al. Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells Hum Mol Genet 21 2012 4021 4029
46. R.S. Patel, S. Su, and I.J. Neeland et al. The chromosome 9p21 risk locus is associated with angiographic severity and progression of coronary artery disease Eur Heart J 31 2010 3017 3023
47. S. Dandona, A.F. Stewart, and L. Chen et al. Gene dosage of the common variant 9p21 predicts severity of coronary artery disease J Am Coll Cardiol 56 2010 479 486
48. K. Chan, R.S. Patel, and P. Newcombe et al. Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis J Am Coll Cardiol 61 2013 957 970
49. K. Chan, A. Motterle, R.C. Laxton, and S. Ye Common variant on chromosome 9p21 predicts severity of coronary artery disease J Am Coll Cardiol 57 2011 1497 1498 author reply 1498-9
50. C.J. O'Donnell, L.A. Cupples, and R.B. D'Agostino et al. Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study BMC Med Genet 8 Suppl 1 2007 S4
51. C.J. O'Donnell, M. Kavousi, and A.V. Smith et al. Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction Circulation 124 2011 2855 2864
52. C. Cluett, M.M. McDermott, and J. Guralnik et al. The 9p21 myocardial infarction risk allele increases risk of peripheral artery disease in older people Circ Cardiovasc Genet 2 2009 347 353
53. R. Virmani, F.D. Kolodgie, A.P. Burke, A. Farb, and S.M. Schwartz Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions Arterioscler Thromb Vasc Biol 20 2000 1262 1275
54. S.E. Nissen, S.J. Nicholls, and I. Sipahi et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial JAMA 295 2006 1556 1565
55. J.W. Jukema, A.V. Bruschke, and A.J. van Boven et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS) Circulation 91 1995 2528 2540
56. D. Shiffman, E.S. O'Meara, and C.M. Rowland et al. The contribution of a 9p21.3 variant, a KIF6 variant, and C-reactive protein to predicting risk of myocardial infarction in a prospective study BMC Cardiovasc Disord 11 2011 10
57. G. Watts UK Biobank opens its data vaults to researchers BMJ 344 2012 e2459